Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Fanasil

 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Sulfadoxine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1979
1979
[Inflammatory tuberculoid leprosy and borderline leprosy treated with long-acting sulfamides (fanasil). Clinical, bacteriologic and immunologic changes in vivo and in vitro followed for 18 to 36…
 
Is this relevant?
1976
1976
A trial of long-acting sulphonamide R.O. 4-4393 (fanasil) in treatment of cases of lepromatous leprosy with repeated E.N.L.
A trial of long-acting Sulphonamide RO.4-4393 (Fanasil) in the treatment of Lepromatous Leprosy patients with repeated E.N.L. is… Expand
Is this relevant?
1971
1971
Blind trial of weekly doses of sulforthomidine (fanasil (Roche)) and Disulone in lepromatous leprosy. Comparison of results after thirty months of treatment.
  • J. Languillon
  • International journal of leprosy and other…
  • 1971
    • Corpus ID: 39894519
 
Is this relevant?
1970
1970
The use of fanasil in mass treatment of trachoma.
  • V P Emiru
  • East African medical journal
  • 1970
    • Corpus ID: 13287941
 
Is this relevant?
1968
1968
[Value of the association of sulformethoxine (fanasil) and pyrimethamine in the radical treatment of malaria due to Plasmodium falciparum].
  • Chum-Chantholl.
  • Bulletin de la Societe de pathologie exotique et…
  • 1968
    • Corpus ID: 34472695
 
Is this relevant?
1966
1966
[Metabolism and therapeutical effect of long-acting sulfonamide 4-sulfanilamido-5,6-dimethoxypyrimidine (Fanasil) in infants and children].
  • M. Vest
  • Schweizerische medizinische Wochenschrift
  • 1966
    • Corpus ID: 42418666
 
Is this relevant?
1966
1966
[Delayed-action sulfonamides: Fanasil. Comprehensive study].
 
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE